Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured By: HETERO LABS LIMITED, Jeedimetla, Hyderabad - 500 055, India, NDC 31722-627-26
Published December 21, 2022 · Recall initiated: December 6, 2022
Summary
FDA records drug Class III recall D-0094-2023, published December 21, 2022 and initiated December 6, 2022. Recalling firm: Camber Pharmaceuticals, Inc; Status: Terminated; Reported quantity: N/A; Lot: Lot#: E222200, E222199, Exp 05/2024; E222228, Exp 06/2024. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content
What to do
Voluntary: Firm initiated · Letter
Get an email if LACOSAMIDE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LACOSAMIDE
- Manufacturer
- Camber Pharmaceuticals, Inc
- Distributor
- USA Nationwide
- UPC
- 0331722627269
- Lot
- Lot#: E222200, E222199, Exp 05/2024; E222228, Exp 06/2024
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, SangareddyJuly 1, 2026
- FDALacosamide Tablets 150mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited,April 16, 2025
- FDALacosamide Tablets, 100mg , 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited,April 16, 2025
- FDALacosamide Tablets 200mg, 60-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited,April 16, 2025
- FDAIohexol (300 mg Iodine/mL), 2.4 g Iodine/8 ml, Total Volume 8 ml in 10 ml syringe, 5-count syringes packagedDecember 21, 2022
- FDAArrow AutoCAT2 Intra-Aortic Balloon Pump, AEROAUTOCAT 2 WAVE, REF IAP-0535 (IPN000329), cardiac pumpDecember 21, 2022
Questions about this recall
Was Lacosamide Oral Solution, USP, CV, 10mg/mL, packaged in 200 mL bottle, Rx Only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, Manufactured By: HETERO LABS LIMITED, Jeedimetla, Hyderabad - 500 055, India, NDC 31722-627-26 recalled?
Yes. FDA published recall D-0094-2023 on December 21, 2022. Reported hazard: Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LACOSAMIDE. UPC: 0331722627269.